ADVATE Post Authorization Safety Surveillance

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

NCT02078427 ·Status: COMPLETED

Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS

NCT02190149 ·Status: COMPLETED

Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens

NCT02314325 ·Status: UNKNOWN ·Phase: PHASE4

Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A

NCT00141843 ·Status: COMPLETED ·Phase: PHASE3

Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901

NCT00157053 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A

NCT00168051 ·Status: WITHDRAWN ·Phase: PHASE4

Study Evaluating ReFacto AF in Severe Hemophilia A

NCT00037544 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

NCT05568719 ·Status: RECRUITING ·Phase: PHASE3

Pharmacokinetic Study of ADVATE Reconstituted in 2 mL Sterile Water for Injection

NCT00952822 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia A

NCT00666406 ·Status: COMPLETED ·Phase: PHASE4

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

NCT01913405 ·Status: COMPLETED ·Phase: PHASE3

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 ·Status: COMPLETED ·Phase: PHASE3

PF-06741086 Multiple Dose Study in Severe Hemophilia

NCT02974855 ·Status: COMPLETED ·Phase: PHASE2

Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment

NCT00623480 ·Status: COMPLETED ·Phase: PHASE3

PF-06741086 Long-term Treatment in Severe Hemophilia

NCT03363321 ·Status: COMPLETED ·Phase: PHASE2

Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors

NCT01234545 ·Status: COMPLETED

A Study of ADVATE in People With Hemophilia A in India

NCT04985682 ·Status: COMPLETED ·Phase: PHASE4

ATHN 7: Hemophilia Natural History Study

NCT03619863 ·Status: COMPLETED

Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia A

NCT01181128 ·Status: COMPLETED ·Phase: PHASE3

Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography

NCT01561924 ·Status: COMPLETED ·Phase: PHASE1

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial

NCT02541942 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

NCT01561391 ·Status: COMPLETED ·Phase: PHASE4

Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B

NCT01220141 ·Status: COMPLETED

High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With Inhibitors

NCT00571584 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia A

NCT00916032 ·Status: COMPLETED ·Phase: PHASE4